Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 30, 2022

How Many Times a Day Should You Pee?

  • Aging & MS
    /
  • Misc. MS Related
    /
  • Urologic Symptoms
    /
 The Unmentionables is a series that answers common questions we all have about our bodies but are sometimes afraid to…
Aging & MS

September 28, 2022

Unhealthy Coping Strategies in MS May Lead to Worse Quality of Life

  • Additional MS resource sites
    /
  • Healthcare Perspectives
    /
  • Misc. MS Related
    /
 New study recommends ‘regular supervision’ of patients’ coping methods article written by: Lindsey Shapiro, PhD  – Sept 26, 2022 ———————————— People…
Additional MS resource sites

September 28, 2022

Guerbet Announces FDA Approval of Elucirem (Gadopiclenol) for Use in Contrast-enhanced MRI

  • MRI
    /
 Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration (FDA) after priority review, approved…
MRI

September 28, 2022

How MS progresses over time / The Expanded Disability Status Scale and what this means

  • MRI
    /
  • Multiple Sclerosis
    /
 Most people with MS experience two stages of disease. The first stage is relapsing-remitting MS (RRMS), which is characterized by episodes of…
MRI

September 27, 2022

Dual Cognitive, Motor Tasks More Difficult Even in Early MS Stages

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
 Dual-tasking cognitive and motor problems seen with mild, moderate disease September 27, 2022 Even in early stages of disease, people…
Multiple Sclerosis

September 26, 2022

Survival Much Higher for MS Patients Who Take DMTs as Directed: Study

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 Medication adherence linked to greater survival for US veterans prescribed DMTs by Marisa Wexler, MS | September 23, 2022 The likelihood of survival…
MS Drug Therapies

September 25, 2022

Novartis to Petition U.S. Supreme Court to Uphold Gilenya Patent

  • MS Drug Therapies
    /
 Novartis said it will petition the U.S. Supreme Court to uphold a patent that protects the dosing regimen of Gilenya (fingolimod) that’s approved…
MS Drug Therapies

September 25, 2022

FDA puts brakes on Sanofi’s $3.7B multiple sclerosis bet, imposing partial hold, over liver injuries

  • MS Drug Therapies
    /
  The $3.7 billion centerpiece of Paul Hudson’s R&D strategy for Sanofi has hit a setback. Seeing cases of drug-induced…
MS Drug Therapies

September 10, 2022

How Age Affects Multiple Sclerosis Symptoms and Progression

  • Multiple Sclerosis
    /
 While age at diagnosis may influence the rate of MS progression, it appears not to be the only factor. By…
Multiple Sclerosis

September 10, 2022

Mindfulness Training Can Help People With Chronic Pain Reduce Their Pain and Dosage of Opioids

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
 In the largest trial of its kind to date, researchers found mindfulness training reduced pain, opioid dosing, and depression for…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

Categories

Latest Blog Posts